Show simple item record

dc.contributor.authorDoshi, Peter
dc.date.accessioned2017-05-25T01:13:55Z
dc.date.available2017-05-25T01:13:55Z
dc.date.issued2014-02-26
dc.identifier.citationDoshi, P. (2014). From promises to policies: is big pharma delivering on transparency? BMJ 2014;348:g1615. DOI: https://doi.org/10.1136/bmj.g1615en_US
dc.identifier.urihttp://hdl.handle.net/10713/6603
dc.descriptionAs increasing numbers of pharmaceutical companies establish policies for granting third party access to their clinical trial data, the onus shifts to those ready to begin sifting through the dataen_US
dc.description.urihttp://bmj.com/cgi/content/full/bmj.g1615?ijkey=xQM0IpzGcVGeI9o&keytype=ref
dc.language.isoen_USen_US
dc.publisherBMJ Publishing Groupen_US
dc.subjectresearch transparencyen_US
dc.subjectdata sharingen_US
dc.subjectdata sharing restrictionsen_US
dc.subject.meshDrug Industryen_US
dc.subject.meshClinical Trials as Topicen_US
dc.subject.meshInformation Dissemination--methodsen_US
dc.titleFrom promises to policies: is big pharma delivering on transparency?en_US
dc.typeArticleen_US
dc.identifier.doi10.1136/bmj.g1615
dc.identifier.pmid24574476
dc.identifier.ispublishedNoen_US
dc.description.urinameClick here for the free full-text article on publisher’s websiteen_US
refterms.dateFOA2019-02-19T18:16:18Z


Files in this item

Thumbnail
Name:
Doshi_BMJ_Promises-2-Policies.pdf
Size:
227.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record